Efavirenzstructure (Efavirenzstructure)
Efavirenz Tablet, Film Coated
Product Images NDC 31722-504
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 31722-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Efavirenztabcamberlogo1 (Efavirenztabcamberlogo1)
Efavirenztabcamberlogo2 (Efavirenztabcamberlogo2)
Efavirenztabcontlabel250s (Efavirenztabcontlabel250s)
This is a description of Efavirenz Tablets, USP manufactured by Camber Pharmaceuticals Inc. It contains 600mg of Efavirenz USP per coated tablet. There is an alert mentioned notifying users of medicines that should not be taken with Efavirenz. The recommended storage temperature ranges between 15° to 30°C (59° to 86°F). The product information should be read before use. There is also a contact number mentioned for the US.*
Efavirenztabcontlabel30s (Efavirenztabcontlabel30s)
This is a medication package insert for Efavirenz Tablets, USP manufactured by Camber Pharmaceuticals, Inc. The medication contains 600mg of efavirenz USP and is used for treatment of HIV. The package insert has an alert section providing information about medicines that should not be taken with efavirenz. The package should be stored at 25° (77°F) with excursions permitted to 16°30°C (59°- 86°F). For dosage and full prescribing information, read accompanying product information. The phone number for US contact is provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
